Barriers and facilitators of adherence to medical advice on skin self-examination during melanoma follow-up care

BMC Family Practice

Gerald Batist⁷  Rosalind Garland³  Adina Coroiu³  Alan Spatz¹  Manish Khanna²  Beatrice Wang⁴  Zeev Rosberger⁵  Brett D Thombs⁶  Martin Drapeau³  Annett Körner³ 

[1] Department of Pathology, Jewish General Hospital, 3755, Chemin de la Côte-Ste-Catherine, Montréal, QC, H3S 1X2, Canada;Department of Dermatology, Jewish General Hospital, 3755, Chemin de la Côte-Ste-Catherine, Montréal, QC, H3S 1X2, Canada;Department of Educational and Counselling Psychology, McGill University, 3700, rue McTavish, Montréal, QC, H3A 1Y2, Canada;Melanoma Clinic, Royal Victoria Hospital, MGill University Health Centre, 687 Pine Avenue West, Montréal, QC, H3A 1A1, Canada;Louise-Granofsky-Psychosocial Oncology Program, Jewish General Hospital, 4333, Chemin de la Côte-Ste-Catherine, Montréal, QC, H3T 1E4, Canada;Lady Davis Institute for Medical Research, Jewish General Hospital, 4333, Chemin de la Côte-Ste-Catherine, Montréal, QC, H3T 1E4, Canada;Segal Cancer Centre, Jewish General Hospital, 3755, Chemin de la Côte-Ste-Catherine, Montréal, QC, H3S 1X2, Canada

关键词: Skin cancer;    Partner support;    Physician support;    Coping;    Distress;    Medical advice;    Skin self-examination;    Health behavior;    Secondary prevention;    Melanoma;   

Others  :  855081
DOI  :  10.1186/1471-5945-13-3

 received in 2013-02-15, accepted in 2013-02-18,  发布年份 2013

【 摘 要 】

Background

Melanoma is the fastest growing tumor of the skin, which disproportionately affects younger and middle-aged adults. As melanomas are visible, recognizable, and highly curable while in early stages, early diagnosis is one of the most effective measures to decrease melanoma-related mortality. Skin self-examination results in earlier detection and removal of the melanoma. Due to the elevated risk of survivors for developing subsequent melanomas, monthly self-exams are strongly recommended as part of follow-up care. Yet, only a minority of high-risk individuals practices systematic and regular self-exams. This can be improved through patient education. However, dermatological education is effective only in about 50% of the cases and little is known about those who do not respond. In the current literature, psychosocial variables like distress, coping with cancer, as well as partner and physician support are widely neglected in relation to the practice of skin self-examination, despite the fact that they have been shown to be essential for other health behaviors and for adherence to medical advice. Moreover, the current body of knowledge is compromised by the inconsistent conceptualization of SSE. The main objective of the current project is to examine psychosocial predictors of skin self-examination using on a rigorous and clinically sound methodology.

Methods/Design

The longitudinal, mixed-method study examines key psychosocial variables related to the acquisition and to the long-term maintenance of skin self-examination in 200 patients with melanoma. Practice of self-exam behaviors is assessed at 3 and 12 months after receiving an educational intervention designed based on best-practice standards. Examined predictors of skin self-exam behaviors include biological sex, perceived self-exam efficacy, distress, partner and physician support, and coping strategies. Qualitative analyses of semi-structured interviews will complement and enlighten the quantitative findings.

Discussion

The identification of short and long-term predictors of skin self-examination and an increased understanding of barriers will allow health care professionals to better address patient difficulties in adhering to this life-saving health behavior. Furthermore, the findings will enable the development and evaluation of evidence-based, comprehensive intervention strategies. Ultimately, these findings could impact a wide range of outreach programs and secondary prevention initiatives for other populations with increased melanoma risk.

【 授权许可】

   
2013 Körner et al; licensee BioMed Central Ltd.

【 参考文献 】

• [1]Bleyer A, O’Leary M, Barr R, Ries LAG (Eds): Cancer Epidemiology in Older Adolescents and Young Adults 15 to 29 Years of Age, Including SEER Incidence and Survival: 1975–2000. Bethesda, MD: National Cancer Institute; 2006. [NIH Pub. No. 06–5767]
• [2]Ries LA, Wingo PA, Miller DS, Howe HL, Weir HK, Rosenberg HM: The annual report to the nation on the status of cancer, 1973–1997, with a special section on colorectal cancer. Cancer 2000, 88:2398-2424.
• [3]Hausauer AK, Swetter SM, Cockburn MG, Clarke CA: Increases in melanoma among adolescent girls and young women in California: trends by socioeconomic status and UV radiation exposure. Arch Dermatol 2011, 147(7):783-789.
• [4]de Vries E, Bray FI, Coebergh JW, Parkin DM: Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia. Int J Cancer 2003, 107:119-126.
• [5]Horner MJ, Ries LAG, Krapcho M, Neyman N, Aminou R, Howlader N, Altekruse SF, Feuer EJ, Huang L, Mariotto A: SEER Cancer Statistics Review, 1975–2006. Bethesda, MD: National Cancer Institute; 2009.
• [6]Safarians S, Sternlight MD, Freiman CJ, Huaman JA, Barsky SH: The primary tumor is the primary source of metastasis in a human melanoma/SCID model. Implications for the direct autocrine and paracrine epigenetic regulation of the metastatic process. Int J Canc 1996, 66(2):151-158.
• [7]Yang EV, Kim SJ, Donovan EL, Chen M, Gross AC, Webster Marketon JI, Barsky SH, Glaser R: Norepinephrine upregulates VEGF, IL-8, and IL-6 expression in human melanoma tumor cell lines: implications for stress-related enhancement of tumor progression. Brain Behav Immun 2009, 23(2):267-275.
• [8]Balch CM, Buzaid AC, Soong SJ, Atkins MB, Cascinelli N, Coit DG: Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol 2001, 19:3635-3648.
• [9]Berwick M, Erdei E, Hay J: Melanoma epidemiology and public health. Dermatol Clin 2009, 27(2):205-214.
• [10]Markovic SN, Erickson LA, Rao RD, Weenig RH, Pockaj BA, Bardia A, Vachon CM, Schild SE, McWilliams RR, Hand JL: Malignant melanoma in the 21st century, part 1: Epidemiology, risk factors, screening, prevention, and diagnosis. Mayo Clin Proc 2007, 82:364-380.
• [11]Rhodes AR: Cutaneous melanoma and intervention strategies to reduce tumor-related mortality: What we know, what we don't know, and what we think we know that isn't so. Dermatol Ther 2006, 19:50-69.
• [12]Geller AC, Swetter SM, Brooks K, Demierre MF, Yaroch AL: Screening, early detection, and trends for melanoma: Current status (2000–2006) and future directions. J Am Acad Dermatol 2007, 57:555-572.
• [13]Burdern AD, Vestey JP, Srel M, Aitchison TC, Hunter JA, MacKie RM: Multiple primary melanoma: Risk factors and prognostic implications. Br Med J 1994, 309:376.
• [14]Uliasz A, Lebwohl M: Patient education and regular surveillance results in earlier diagnosis of second primary melanoma. Int J Dermatol 2007, 46:575-577.
• [15]Ferrone CR, Ben Porat L, Panageas KS, Berwick M, Halpern AC, Patel A: Clinicopathological features of and risk factors for multiple primary melanomas. J Am Med Assoc 2005, 294:1647-1654.
• [16]Kang S, Barnhill RL, Mihm MC, Sober AJ: Multiple primary cutaneous melanomas. Cancer 1992, 70(7):1911-1916.
• [17]Manganoni AM, Farisoglio C, Tucci G, Facchetti F, Calzavara Pinton PG: The importance of self-examination in the earliest diagnosis of multiple primary cutaneous melanomas: A report of 47 cases. J Eur Acad Dermatol Venereol 2007, 21:1333-1336.
• [18]Stam-Posthuma JJ, Van Duinen C, Scheffer E, Vink J, Bergman W: Multiple primary melanoma. J Am Acad Dermatol 2001, 44:22-27.
• [19]Garbe C, Paul A, Kohler-Spath H, Ellwanger U, Stroebel W, Schwarz M: Prospective evaluation of a follow-up schedule in cutaneous melanoma patients: Recommendations for an effective follow-up strategy. J Clin Oncol 2003, 21:520-529.
• [20]Weinstock MA: Progress and prospects on melanoma: The way forward for early detection and reduced mortality. Clin Cancer Res 2006, 12:2297-2300.
• [21]Berwick M, Armstrong BK, Ben-Porat L, Fine J, Kricker A, Eberle C: Sun exposure and mortality from melanoma. J Natl Cancer Inst 2005, 97:195-199.
• [22]Cokkinides V, Weinstock M, Glanz K, Albano J, Ward E, Thun M: Trends in sunburns, sun protection practices, and attitudes toward sun exposure protection and tanning among US adolescents, 1998–2004. Pediatrics 2006, 118:853-864.
• [23]Gandini S, Sera F, Cattaruzza MS, Pasquini P, Picconi O, Boyle P: Meta-analysis of risk factors for cutaneous melanoma: II. Sun exposure. Eur J Cancer 2005, 41:45-60.
• [24]Kennedy C, Bajdik CD, Willemze R, De Gruijl FR, Bouwes Bavinck JN: The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer. J Invest Dermatol 2003, 120:1087-1093.
• [25]Kasparian N, McLoone J, Meiser B: Skin cancer-related prevention and screening behaviors: a review of the literature. J Behav Med 2009, 32(5):406-428.
• [26]Brady MS, Oliveria SA, Christos PJ, Berwick M, Coit DG, Katz J: Patterns of detection in patients with cutaneous melanoma. Cancer 2000, 89:342-347.
• [27]Carli P, De Giorgi V, Palli D, Maurichi A, Mulas P, Orlandi C: Dermatologist detection and skin self-examination are associated with thinner melanomas: Results from a survey of the Italian Multidisciplinary Group on Melanoma. Arch Dermatol 2003, 139:607-612.
• [28]Epstein DS, Lange JR, Gruber SB, Mofid M, Koch SE: Is physician detection associated with thinner melanomas? J Am Med Assoc 1999, 281:640-643.
• [29]Schwartz JL, Wang TS, Hamilton TA, Lowe L, Sondak VK, Johnson TM: Thin primary melanomas: associated detection patterns, lesion characteristics, and patient characteristics. Cancer 2002, 95:1562-1568.
• [30]Körner A, Coroiu A, Martins C, Wang B: Predictors of skin self-examination before and after a melanoma diagnosis: The role of medical advice and patient’s level of education. Int Arch Med 2013, 6:8. BioMed Central Full Text
• [31]Schneider JS, Moore DH 2nd, Mendelsohn ML: Screening program reduced melanoma mortality at the Lawrence Livermore National Laboratory, 1984 to 1996. J Am Acad Dermatol 2008, 58:741-749.
• [32]Aitken JF, Janda M, Elwood M, Youl PH, Ring IT, Lowe JB: Clinical outcomes from skin screening clinics within a community-based melanoma screening program. J Am Acad Dermatol 2006, 54:105-114.
• [33]Aitken JF, Youl PH, Janda M, Lowe JB, Ring IT, Elwood M: Increase in skin cancer screening during a community-based randomized intervention trial. Int J Cancer 2006, 118:1010-1016.
• [34]Berwick M, Begg CB, Fine JA, Roush GC, Barnhill RL: Screening for cutaneous melanoma by skin self-examination. J Natl Cancer Inst 1996, 88:17-23.
• [35]Dalal KM, Zhou Q, Panageas KS, Brady MS, Jaques DP, Coit DG: Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy. Ann Surg Oncol 2008, 15:2206-2214.
• [36]Coit DG, Andtbacka R, Anker CJ, Bichakjian CK, Carson WE, Daud A, Dilawari RA, DiMaio D, Guild V, Halpern AC: NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®): Melanoma. J Natl Compr Canc Netw 2012, 10(3):366-400.
• [37]National Cancer Institute: What You Need To Know About™ Melanoma and Other Skin Cancers. Rockville, MD; 2010.
• [38]American Cancer Society: Skin Cancer - Melanoma: Early Detection, Diagnosis, and Staging. [http://www.cancer.org/cancer/skincancer-melanoma/overviewguide/melanoma-skin-cancer-overview-diagnosed webcite]
• [39]American Academy of Dermatology: Skin Exams Save Lifes: Body Mole Map. [http://www.aad.org/spot-skin-cancer/understanding-skin-cancer/how-do-i-check-my-skin webcite]
• [40]Robinson JK, Fisher SG, Turrisi RJ: Predictors of skin self-examination performance. Cancer 2002, 95:135-146.
• [41]Geller AC, O'Riordan DL, Oliveria SA, Valvo S, Teich M, Halpern AC: Overcoming Obstacles to Skin Cancer Examinations and Prevention Counseling for High-Risk Patients: Results of a National Survey of Primary Care Physicians. J Am Board Fam Pract 2004, 17(6):416-423.
• [42]Robinson JK, Mallett KA, Turrisi R, Stapleton J, Robinson JK, Mallett KA, Turrisi R, Stapleton J: Engaging Patients and their Partners in Preventive Health Behaviors: The Physician Factor. Arch Dermatol 2009, 145(4):469-473.
• [43]Koh HK, Miller DR, Geller AC, Clapp RW, Mercer MB, Lew RA: Who discovers melanoma? Patterns from a population-based survey. J Am Acad Dermatol 1992, 26(6):914-919.
• [44]Terushkin V, Halpern AC: Melanoma early detection. Hematol Oncol Clin North Am 2009, 23(3):481-500.
• [45]Manne S, Lessin S: Prevalence and correlates of sun protection and skin self-examination practices among cutaneous malignant melanoma survivors. J Behav Med 2006, 29:419-434.
• [46]Mujumdar UJ, Hay JL, Monroe-Hinds YC, Hummer AJ, Begg CB, Wilcox HB, Oliveria SA, Berwick M: Sun protection and skin self-examination in melanoma survivors. Psychooncology 2009, 18(10):1106-1115.
• [47]DiFronzo LA, Wanek LA, Morton DL: Earlier diagnosis of second primary melanoma confirms the benefits of patient education and routine postoperative follow-up. Cancer 2001, 91:1520-1524.
• [48]Friedman RJ, Rigel DS, Silverman MK, Kopf AW, Vossaert KA: Malignant melanoma in the 1990s: The continued importance of early detection and the role of physician examination and self-examination of the skin. Canc J Clin 1991, 41(4):201-226.
• [49]Azzarello LM, Dessureault S, Jacobsen PB: Sun-protective behavior among individuals with a family history of melanoma. Cancer Epidemiol Biomarkers Prev 2006, 15(1):142-145.
• [50]Robinson JK, Turrisi R, Stapleton J: Efficacy of a partner assistance intervention designed to increase skin self-examination performance. Arch Dermatol 2007, 143:37-41.
• [51]Robinson JK, Stapleton J, Turrisi R: Relationship and partner moderator variables increase self-efficacy of performing skin self-examination. J Am Acad Dermatol 2008, 58:755-762.
• [52]Robinson JK, Turrisi R, Stapleton J: Examination of mediating variables in a partner assistance intervention designed to increase performance of skin self-examination. J Am Acad Dermatol 2007, 56:391-397.
• [53]Körner A, Augustin M, Zschocke I: Health behaviors of skin cancer patients in melanoma follow-up care. Z Gesundh 2011, 19(1):2-12.
• [54]Chiu V, Won E, Malik M, Weinstock MA: The use of mole-mapping diagrams to increase skin self-examination accuracy. J Am Acad Dermatol 2006, 55(2):245-250.
• [55]Robinson JK, Rigel DS, Amonette RA: What promotes skin self-examination? J Am Acad Dermatol 1998, 38:752-757.
• [56]Berwick M, Oliveria S, Luo ST, Headley A, Bolognia JL: A pilot study using nurse education as an intervention to increase skin self-examination for melanoma. J Cancer Educ 2000, 15:38-40.
• [57]Oliveria SA, Dusza SW, Phelan DL, Ostroff JS, Berwick M, Halpern AC: Patient adherence to skin self-examination effect on nurse intervention with photographs. Am J Prev Med 2004, 26:152-155.
• [58]Weinstock MA, Risica PM, Martin RA, Rakowski W, Smith KJ, Berwick M: Reliability of assessment and circumstances of performance of thorough skin self-examination for the early detection of melanoma in the Check-It-Out Project. Prev Med 2004, 38:761-765.
• [59]Hamidi R, Peng D, Cockburn M: Efficacy of skin self-examination for the early detection of melanoma. Int J Dermatol 2010, 49(2):126-134.
• [60]Kasparian NA, Branstrom R, Chang YM, Affleck P, Aspinwall LG, Tibben A, Azizi E, Baron-Epel O, Battistuzzi L, Bruno W: Skin examination behavior: The role of melanoma history, skin type, psychosocial factors, and region of residence in determining clinical and self-conducted skin examination. Arch Dermatol 2012, 148(10):1-10.
• [61]McPherson M, Elwood M, English DR, Baade PD, Youl PH, Aitken JF: Presentation and detection of invasive melanoma in a high-risk population. J Am Acad Dermatol 2006, 54(5):783-792.
• [62]DiMatteo MR, Giordani PJ, Lepper HS, Croghan TW: Patient adherence and medical treatment outcomes: A meta-analysis. Med Care 2002, 40(9):794-811.
• [63]DiMatteo MR, Lepper HS, Croghan TW: Depression is a risk factor for noncompliance with medical treatment: Meta-analysis of the effects of anxiety and depression on patient adherence. Arch Intern Med 2000, 160:2101-2107.
• [64]Hay JL, Buckley TR, Ostroff JS: The role of cancer worry in cancer screening: A theoretical and empirical review of the literature. Psychooncology 2005, 14(7):517-534.
• [65]Hay JL, Oliveria SA, Dusza SW, Phelan DL, Ostroff JS, Halpern AC: Psychosocial mediators of a nurse intervention to increase skin self-examination in patients at high risk for melanoma. Canc Epidemiol Biomarkers Prev 2006, 15:1212-1216.
• [66]Zschocke I, Rhein J, Grimme H, Stein B, Muthny FA, Augustin M: Self-examination of patients with malignant melanoma in the aftercare: Relevance of psychosocial factors and instructions by the physicians. Dermatol Psychosom 2000, 1:8-14.
• [67]Roberts N, Czajkowska Z, Radiotis G, Körner A: Distress and coping strategies among patients with skin cancer. J Clin Psychol Med Settings 2012,  .
• [68]Hamama-Raz Y, Solomon Z, Schachter J, Azizi E: Objective and subjective stressors and the psychological adjustment of melanoma survivors. Psychooncology 2007, 16:287-294.
• [69]Sollner W, Zschocke I, Zingg-Schir M, Stein B, Rumpold G, Fritsch P, Augustin M: Interactive patterns of social support and individual coping strategies in melanoma patients and their correlations with adjustment to illness. Psychosomatics 1999, 40(3):239-250.
• [70]Temoshok L: Malignant melanoma, AIDS, and the complex search for psychosocial mechanisms. Advances 1991, 7:20-28.
• [71]Kneier AW: The psychological challenges facing melanoma patients. Surg Clin North Am 1996, 76(6):1413-1421.
• [72]Kneier AW, Temoshok L: Repressive coping reactions in patients with malignant melanoma as compared to cardiovascular disease patients. J Psychosom Res 1984, 28(2):145-155.
• [73]Lichtenthal W, Cruess DG, Schuchter LM, Ming ME: Psychosocial factors related to the correspondence of recipient and provider perceptions of social support among patients diagnosed with or at risk for malignant melanoma. J Health Psychol 2003, 8(6):705-719.
• [74]Dirksen S: Perceived well-being in malignant melanoma survivors. Oncol Nurs Forum 1989, 16(3):353-358.
• [75]Kasparian NA, McLoone JK, Butow PN: Psychological responses and coping strategies among patients with malignant melanoma: a systematic review of the literature. Arch Dermatol 2009, 145(12):1415-1427.
• [76]Glanz K, Lewis FM, Rimer BK: Health behavior and health education: Theory, research, and practice. 4th edition. San Francisco, CA: Jossey-Bass; 2008.
• [77]Cancer Registry - McGill University Health Centre: Prevalence of cutaneous melanoma at the McGill University Health Centre in 2000–2007. Montreal, QC: McGill University Health Centre; 2009.
• [78]Prevalence of cutaneous melanoma at the Jewish General Hospital in 2005-2007: Title. Thesis Type. Jewish General Hospital: University; 2008.
• [79]Khanna M, Fortier-Riberdy G, Smoller B, Dinehart SM: Reporting tumor thickness for cutaneous squamous cell carcinoma. J Cutan Pathol 2002, 29:321-323.
• [80]Lebel S, Jakubovits G, Rosberger Z, Loiselle C, Seguin C, Cornaz C, Ingram J, August L, Lisbona A: Waiting for a breast biopsy. Psychosocial consequences and coping strategies. J Psychosom Res 2003, 55(5):437-443.
• [81]Couper JWBS, Love A, Duchesne G, Macvean M, Kissane DW: The psychosocial impact of prostate cancer on patients and their partners. Med J Aust 2006, 185(8):428-432.
• [82]Hersch J, Juraskova I, Price M, Mullan B: Psychosocial interventions and quality of life in gynaecological cancer patients: A systematic review. Psychooncology 2009, 18:795-810.
• [83]Dale HLAP, Humphris GM: Systematic review of post-treatment psychosocial and behaviour change interventions for men with cancer. Psychooncology 2010, 19:227-237.
• [84]Schou I, Ekeberg O, Karesen R, Sorensen E: Psychosocial intervention as a component of routine breast cancer care—who participates and does it help? Psychooncology 2008, 17(7):716-720.
• [85]Lebel S, Rosberger Z, Edgar L, Devins GM: Predicting stress-related problems in long-term breast cancer survivors. J Psychosom Res 2008, 65:513-523.
• [86]Moadel AB, Shah C, Wylie-Rosett J, Harris MS, Patel SR, Hall CB, Sparano JA: Randomized Controlled Trial of Yoga Among a Multiethnic Sample of Breast Cancer Patients: Effects on Quality of Life. J Clin Oncol 2007, 25(28):4387-4395.
• [87]Antoni MH, Wimberly SR, Lechner SC, Kazi A, Sifre T, Urcuyo KR, Phillips K, Smith RG, Petronis VM, Guellati S: Reduction of Cancer-Specific Thought Intrusions and Anxiety Symptoms With a Stress Management Intervention Among Women Undergoing Treatment for Breast Cancer. Am J Psychiatry 2006, 163(10):1791-1797.
• [88]McCorkle R, Dowd M, Ercolano E, Schulman-Green D, Williams A, Siefert ML, Steiner J, Schwartz P: Effects of a nursing intervention on quality of life outcomes in post-surgical women with gynecological cancers. Psychooncology 2009, 18(1):62-70.
• [89]Manne SL, Rubin S, Edelson M, Rosenblum N, Bergman C, Hernandez E, Carlson J, Rocereto T, Winkel G: Coping and Communication-Enhancing Intervention Versus Supportive Counseling for Women Diagnosed With Gynecological Cancers. J Consult Clin Psychol 2007, 75(4):615-628.
• [90]Velji K: Effect of an individualized symptom education program on the symptom distress of women receiving radiation therapy for gynecological cancers. Toronto: University of Toronto; 2006.
• [91]Nolte S, Donnelly J, Kelly S, Conley P, Cobb R: A randomized clinical trial of a videotape intervention for women with chemotherapy-induced alopecia: a gynecologic oncology group study. Oncol Nurs Forum 2006, 33(2):305-311.
• [92]Chan YM, Lee PWH, Fong DYT, Fung ASM, Wu LYF, Choi AYY, Ng TY, Ngan HYS, Wong LC: Effect of Individual Psychological Intervention in Chinese Women With Gynecologic Malignancy: A Randomized Controlled Trial. J Clin Oncol 2005, 23(22):4913-4924.
• [93]Geller AC, Emmons KM, Brooks DR, Powers C, Zhang Z, Koh HK, Heeren T, Sober AJ, Li F, Gilchrest BA: A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer 2006, 107(4):806-814.
• [94]Andersen BL: Biobehavioral outcomes following psychological interventions for cancer patients. J Consult Clin Psychol 2002, 70(3):590-610.
• [95]Centre for Reviews and Dissemination: The effects of psychosocial interventions in cancer and heart disease: a review of systematic reviews. York: University of York; 2005. [CRD Report 30]
• [96]Lostumbo L, Carbine N, Wallace J, Ezzo J: Prophylactic mastectomy for the prevention of breast cancer. Cochrane Database Syst Rev 2010, CD002748.
• [97]Nezu AM, Nezu CM, Felgoise SH, McClure KS, Houts PS, Nezu AM, Nezu CM, Felgoise SH, McClure KS, Houts PS: Project Genesis: assessing the efficacy of problem-solving therapy for distressed adult cancer patients. J Consult Clin Psychol 2003, 71(6):1036-1048.
• [98]Boone SL, Stapleton J, Turrisi R, Ortiz S, Robinson JK, Mallett KA, Boone SL, Stapleton J, Turrisi R, Ortiz S: Thoroughness of skin examination by melanoma patients: influence of age, sex and partner. Australas J Dermatol 2009, 50(3):176-180.
• [99]Blum A, Brand CU, Ellwanger U, Schlagenhauff W, Stroebel W, Rassner G: Awareness and early detection of cutaneous melanoma: An analysis of factors related to delay in treatment. Br J Dermatol 1999, 141:783-787.
• [100]Francken A, Thompson JF, Bastiaannet E, Hoekstra HJ: Detection of the first recurrence in patients with melanoma: three quarters by the patient, one quarter during outpatient follow-up. Ned Tijdschr Geneeskd 2008, 152:557-562.
• [101]Carli P, DeGiorgi V, Chiarugi A, Stante M, Giannotti B: Multiple synchronous cutaneous melanomas: implications for prevention. Int J Dermatol 2002, 41(9):583-585.
• [102]Goggins WB, Tsao H: A population-based analysis of risk factors for a second primary cutaneous melanoma among melanoma survivors. Cancer 2003, 97:639-643.
• [103]Walter FM, Humphrys E, Tso S, Johnson M, Cohn S: Patient understanding of moles and skin cancer, and factors influencing presentation in primary care: a qualitative study. BMC Fam Pract 2010, 11(62):1471-2296.
• [104]Francken AB, Shaw HM, Accortt NA, Soong SJ, Hoekstra HJ, Thompson JF: Detection of first relapse in cutaneous melanoma patients: implications for the formulation of evidence-based follow-up guidelines. Ann Surg Oncol 2007, 14:1924-1933.
• [105]Melanoma Network of Canada: About melanoma: Detection & Prevention.
• [106]Murchie P, Hannaford PC, Wyke S, Nicolson MC, Campbell NC: Designing an integrated follow-up programme for people treated for cutaneous malignant melanoma: A practical application of the MRC framework for the design and evaluation of complex interventions to improve health. Fam Pract 2007, 24:283-292.
• [107]Garbe C, Hauschild A, Volkenandt M, Schadendorf D, Stolz W, Reinhold U: Evidence and interdisciplinary consensus-based German guidelines: Diagnosis and surveillance of melanoma. Melanoma Res 2007, 17(6):393-399.
• [108]American Academy of Dermatology: Guidelines for Performing a Skin Self-Exam. [http://www.aad.org/spot-skin-cancer/understanding-skin-cancer/how-do-i-check-my-skin webcite]
• [109]National Institutes of Health Consensus Development Program: Diagnosis and Treatment of Early Melanoma. NIH Consens Statement Online 1992 Jan 27–29;10(1):1–26. [http://consensus.nih.gov/1992/1992Melanoma088html.htm webcite]
• [110]Abbasi NR, Shaw HM, Rigel DS, Friedman RJ, McCarthy WH, Osman I, Kopf AW, Polsky D: Early diagnosis of cutaneous melanoma: Revisiting the ABCD criteria. J Am Med Assoc 2004, 292:2771-2776.
• [111]Canadian Dermatology Association: The ABCDEs of Malignant Melanoma. 2008.
• [112]Rigel DS, Russak J, Friedman R: The Evolution of Melanoma Diagnosis: 25 Years Beyond the ABCDs. Canc J Clin 2010, 60(5):301-316.
• [113]Rigel DS, Friedman RJ, Kopf AW, Polsky D: ABCDE - an evolving concept in the early detection of melanoma. Arch Dermatol 2005, 141:1032-1034.
• [114]Canadian Dermatology Association: Brochure - Malignant Melanoma. Public education material. Ottawa, ON; 2008.
• [115]La Roche-Posay Laboratoire Dermatologique: Before showing it to the sun, show it to a dermatologist. Patient Education Material. Montreal, QC; 2012.
• [116]Körner A: Skin Self-Examination Journal. Unpublished patient education material. QC, Montreal: McGill University, Department of Educational and Counselling Psychology; 2011.
• [117]Moumne S, Czajkowska Z, Wang B, Khanna M, Körner A: The body map diary: Research tool and means for secondary prevention of melanoma. In Poster presented at the Annual conference of the Canadian Association of Psychosocial Oncology (CAPO): May 2011; Toronto, Canada. : ; 2011.
• [118]Groleau D, Young A, Kirmayer LJ: The McGill Illness Narrative Interview (MINI): an interview schedule to elicits meanings and modes of reasoning related to illness experience. Transcult Psychiatry 2006, 43(4):671-691.
• [119]Miller DR, Geller AC, Wyatt SW, Halpern A, Howell JB, Cockerell C, Reilley BA, Bewerse BA, Rigel D, Rosenthal L, Amonette R, Sun T, Grossbart T, Lew RA, Koh HK: Melanoma awareness and self-examination practices: results of a United States survey. J Am Acad Dermatol 1996, 34(6):962-970.
• [120]Geller AC: Educational and screening campaigns to reduce deaths from melanoma. Hematol Oncol Clin North Am 2009, 23(3):515-527.
• [121]Swetter S, Johnson T, Miller D, Layton C, Brooks K, Geller A: Melanoma in middle-aged and older men: a multi-institutional survey study of factors related to tumor thickness. Arch Dermatol 2009, 145(4):397-404.
• [122]Körner A: Adherence to medical advice - Understanding barriers and facilitators of skin self- examination in patients with melanoma. Montreal, QC: McGill University Health Centre; 2010. [Ethics application for pilot study no. 10-126-PSY]
• [123]Weinstock MA, Risica PM, Martin RA, Rakowski W, Dube C, Berwick M: Melanoma early detection with thorough skin self-examination: The "Check It Out" randomized trial. Am J Prev Med 2007, 32:517-524.
• [124]Körner A: Reducing Melanoma-Related Mortality in High Risk Individuals: Barriers and Facilitators of Adherence to Skin Self-Examination. Montreal, QC: Faculty of Medicine, McGill University; 2011. [Research protocol no. A00-B39-11B approved by the Institutional Review Board]
• [125]Schulz U, Schwarzer R: Long-term effects of spousal support on coping with cancer after surgery. J Soc Clin Psychol 2004, 23(5):716-732.
• [126]Matthews BA, Rhee JS, Neuburg M, Burzynski ML, Nattinger AB: Development of the facial skin care index: a health-related outcome index for skin cancer patients. Dermatol Surg 2006, 32(7):924-934.
• [127]Rhee J, Matthews B, Neuburg M, Logan B, Burzynski M, Nattinger A: The skin cancer index: clinical responsiveness and predictors of quality of life. Laryngoscope 2007, 117(3):399-405.
• [128]Kroenke K, Spitzer RL, Williams JB, Lowe B: The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: A systematic review. Gen Hosp Psychiatry 2010, 32(4):345-359.
• [129]Carver CS, Scheier MF, Weintraub JK: Assessing Coping Strategies - a Theoretically Based Approach. J Pers Soc Psychol 1989, 56(2):267-283.
• [130]Canadian Dermatology Association: A Guide to Skin Cancer Self-Examination. Ottawa, ON; 2008.
• [131]Hill CE, Thompson BJ, Williams EN: A guide to conducting consensual qualitative research. Counsel Psychol 1997, 25(4):517-572.
• [132]Hill C, Knox S, Thompson B, Nutt EW, Hess SA: Consensual qualitative research: An update. Counsel Psychol 2005, 52:162-205.
• [133]Paulus T, Woodside M, Ziegler M: Extending the conversation: Qualitative research as dialogic collaborative process. Qual Rep 2008, 13:226-243.
• [134]Strauss A, Corbin J: Basics of qualitative research: Techniques and procedures for developing grounded theory. 2nd edition. Thousand Oaks, CA: Sage; 1998.